Cargando…
Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632681/ https://www.ncbi.nlm.nih.gov/pubmed/34145373 http://dx.doi.org/10.1038/s41375-021-01324-z |
| _version_ | 1784607796591853568 |
|---|---|
| author | Graham, Charlotte Elizabeth Jozwik, Agnieszka Quartey-Papafio, Ruby Ioannou, Nikolaos Metelo, Ana M. Scala, Carlo Dickson, Glenda Stewart, Orla Almena-Carrasco, Maria Peranzoni, Elisa Ramsay, Alan G. Patten, Piers E. M. Pertel, Thomas Farzaneh, Farzin Dupouy, Sandra Pepper, Andrea Benjamin, Reuben |
| author_facet | Graham, Charlotte Elizabeth Jozwik, Agnieszka Quartey-Papafio, Ruby Ioannou, Nikolaos Metelo, Ana M. Scala, Carlo Dickson, Glenda Stewart, Orla Almena-Carrasco, Maria Peranzoni, Elisa Ramsay, Alan G. Patten, Piers E. M. Pertel, Thomas Farzaneh, Farzin Dupouy, Sandra Pepper, Andrea Benjamin, Reuben |
| author_sort | Graham, Charlotte Elizabeth |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8632681 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86326812021-12-15 Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma Graham, Charlotte Elizabeth Jozwik, Agnieszka Quartey-Papafio, Ruby Ioannou, Nikolaos Metelo, Ana M. Scala, Carlo Dickson, Glenda Stewart, Orla Almena-Carrasco, Maria Peranzoni, Elisa Ramsay, Alan G. Patten, Piers E. M. Pertel, Thomas Farzaneh, Farzin Dupouy, Sandra Pepper, Andrea Benjamin, Reuben Leukemia Letter Nature Publishing Group UK 2021-06-18 2021 /pmc/articles/PMC8632681/ /pubmed/34145373 http://dx.doi.org/10.1038/s41375-021-01324-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Graham, Charlotte Elizabeth Jozwik, Agnieszka Quartey-Papafio, Ruby Ioannou, Nikolaos Metelo, Ana M. Scala, Carlo Dickson, Glenda Stewart, Orla Almena-Carrasco, Maria Peranzoni, Elisa Ramsay, Alan G. Patten, Piers E. M. Pertel, Thomas Farzaneh, Farzin Dupouy, Sandra Pepper, Andrea Benjamin, Reuben Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma |
| title | Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma |
| title_full | Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma |
| title_fullStr | Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma |
| title_full_unstemmed | Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma |
| title_short | Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma |
| title_sort | gene-edited healthy donor car t cells show superior anti-tumour activity compared to car t cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632681/ https://www.ncbi.nlm.nih.gov/pubmed/34145373 http://dx.doi.org/10.1038/s41375-021-01324-z |
| work_keys_str_mv | AT grahamcharlotteelizabeth geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT jozwikagnieszka geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT quarteypapafioruby geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT ioannounikolaos geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT meteloanam geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT scalacarlo geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT dicksonglenda geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT stewartorla geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT almenacarrascomaria geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT peranzonielisa geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT ramsayalang geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT pattenpiersem geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT pertelthomas geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT farzanehfarzin geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT dupouysandra geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT pepperandrea geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma AT benjaminreuben geneeditedhealthydonorcartcellsshowsuperiorantitumouractivitycomparedtocartcellsderivedfrompatientswithlymphomainaninvivomodelofhighgradelymphoma |